Transplantation Medicine
Clinical research at Bellvitge University Hospital includes kidney transplantation, renal transplant care, and complications affecting graft function and post-transplant recovery. The studies address post-transplant diabetes, graft pyelonephritis, and post-transplant glomerulopathy.
- Kidney transplant recipients
- Graft pyelonephritis
- Post-transplant diabetes
- Metabolic syndrome
Research activity also extends to patients on the kidney transplantation waiting list, with attention to metabolic and infectious risks before and after transplantation.
Infectious Diseases
The sponsor supports trials in human papillomavirus transmission, latent tuberculosis infection, and bacterial infection management in transplanted kidneys. These studies focus on infectious burden in immunocompromised and transplant-related populations.
- HPV infectivity
- Latent tuberculosis
- Kidney graft infection
- Transplant-related infection prevention
Its portfolio includes infection-related outcomes in end-stage kidney disease and in women with HPV positivity, reflecting a strong interest in prevention and infectious risk reduction.
Autoimmune Neurology
Bellvitge University Hospital is involved in research on generalized myasthenia gravis, with emphasis on symptomatic control and functional improvement in patients with anti-AChR antibodies.
- Generalized myasthenia gravis
- Neuromuscular weakness
- Autoantibody-mediated disease
This area highlights interest in autoimmune neuromuscular disorders and their impact on daily functioning.
Endocrine and Metabolic Disorders
The hospital’s trials include hypothyroidism, metabolic syndrome, and prevention of new-onset diabetes after transplantation. The research focus spans endocrine balance, metabolic risk, and complications linked to transplant care.
- Hypothyroidism
- Metabolic syndrome
- Post-transplant diabetes
- Thyroid surgery-related hypoparathyroidism
Additional work includes surgical preservation of the parathyroid glands during thyroidectomy, linking endocrine surgery with metabolic outcomes.
Rare Diseases
The research portfolio also covers Type C Niemann-Pick disease, a rare neurodegenerative disorder associated with cognitive impairment and complex clinical management.
- Type C Niemann-Pick disease
- Cognitive impairment
- Rare neurodegenerative disease
This area adds a distinct orphan disease dimension to the sponsor’s clinical research profile.
